The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

 

Boston Scientific Corp

NYSE: BSX
Last

(U.S.) $13.02

Today's change0.00 0.00%
Updated December 17 4:00 PM EST. Delayed by at least 15 minutes.
 

Boston Scientific Corp

NYSE: BSX
Last

(U.S.) $13.02

Today's change0.00 0.00%
Updated December 17 4:00 PM EST. Delayed by at least 15 minutes.

Boston Scientific Corp closed at (U.S.)$13.02.

Over the last five days, shares have gained 3.33% and 8.32% year to date. Shares have performed in-line with the S&P 500 during the last year.

Key company metrics

  • Open(U.S.) $12.99
  • Previous close(U.S.) $13.02
  • High(U.S.) $13.04
  • Low(U.S.) $12.74
  • Bid / Ask-- / --
  • YTD % change+8.32%
  • Volume12,873,145
  • Average volume (10-day)13,054,606
  • Average volume (1-month)12,810,803
  • Average volume (3-month)12,653,868
  • 52-week range(U.S.) $11.10 to (U.S.) $14.08
  • Beta1.02
  • Trailing P/E60.24×
  • P/E 1 year forward15.71×
  • Forward PEG1.49×
  • Indicated annual dividend--
  • Dividend yield0.00%
  • Trailing EPS(U.S.) $0.22
Updated December 17 4:00 PM EST. Delayed by at least 15 minutes.

Profit

Net Profit (TTM)
+3.93%

Based on its net profit margin of 3.93%, Boston Scientific Corp is less effective than other companies in its industry at turning revenues into bottom line profit.
Company Books

S&P TSX2.54%Sector:HealthcareIndustry:Advanced Medical Equipment
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q3/2014Q2/2014Q1/2014Q4/2013
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedSep 30, 201409/30/2014Jun 30, 201406/30/2014Mar 31, 201403/31/2014Dec 31, 201312/31/2013
Revenue1,8461,8731,7741,838
Total other revenue--------
Total revenue1,8461,8731,7741,838
Gross profit1,3051,3141,2391,282
Total cost of revenue541559535556
Total operating expense1,7821,9421,5771,712
Selling / general / administrative735737660717
Research & development212206191217
Depreciation / amortization109109109105
Interest expense (income), net operating--------
Unusual expense (income)1643064292
Other operating expenses, total21254025
Operating income64-69197126
Interest income (expense), net non-operating-54-53-54-58
Gain (loss) on sale of assets--------
Other--------
Income before tax3-10414659
Income after tax434133108
Income tax, total-40-10813-49
Net income434133108
Total adjustments to net income--------
Net income before extra. items434133108
Minority interest--------
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items434133108
Inc. avail. to common incl. extra. items434133108
Diluted net income434135108
Dilution adjustment----20
Diluted weighted average shares1,3481,3451,3491,329
Diluted EPS excluding extraordinary itemsvalue per share0.030.000.100.08
Dividends per sharevalue per share0.000.000.000.00
Diluted normalized EPSvalue per share0.110.150.120.13